Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Xetra  >  Fresenius Medical Care AG & Co. KGaA    FME   DE0005785802

FRESENIUS MEDICAL CARE AG & CO. KGAA

(FME)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Xetra
07/28/2020 07/29/2020 07/30/2020 07/31/2020 08/03/2020 Date
76.86(c) 78.58(c) 74.04(c) 74.62(c) 76.26 Last
521 867 640 195 1 390 971 921 111 623 630 Volume
-0.16% +2.24% -5.78% +0.78% +2.20% Change
More quotes
Financials (USD)
Sales 2020 21 413 M - -
Net income 2020 1 532 M - -
Net Debt 2020 15 087 M - -
P/E ratio 2020 16,6x
Yield 2020 1,55%
Sales 2021 22 362 M - -
Net income 2021 1 690 M - -
Net Debt 2021 12 824 M - -
P/E ratio 2021 15,3x
Yield 2021 1,67%
Capitalization 25 719 M 25 848 M -
EV / Sales 2020 1,91x
EV / Sales 2021 1,72x
Nbr of Employees 124 736
Free-Float 65,2%
More Financials
Company
Fresenius Medical Care AG & Co. KGaA is the world's leading supplier of services and equipment for patients with kidney problems. Net sales break down by activity as follows: - clinical care services (79.4%): operated, at the end of 2019, 3,994 institutions; - manufacturing of dialyzers and related products (20.6%): hemo-dialysis and pediatric dialysis machines, etc. The group also offers therapies accompanied... 
More about the company
Surperformance© ratings of Fresenius Medical Care AG
Trading Rating : Investor Rating :
More Ratings
Latest news on FRESENIUS MEDICAL CARE AG
11:09aFMC FRESENIUS MEDICAL CARE AG & CO K : Gets a Buy rating from DZ Bank
MD
07/31FRESENIUS SE : Credit Suisse remains Neutral
MD
07/31FMC FRESENIUS MEDICAL CARE AG & CO K : Gets a Neutral rating from Credit Suisse
MD
07/31European Companies Begin Reinstating Guidance After Coronavirus Upheaval
DJ
07/31FRESENIUS SE : Independant Research maintains a Buy rating
MD
07/31FMC FRESENIUS MEDICAL CARE AG & CO K : Raised to Buy by Independant Research
MD
07/31FMC FRESENIUS MEDICAL CARE AG & CO K : Deutsche Bank reiterates its Buy rating
MD
07/31FRESENIUS SE : Deutsche Bank maintains a Buy rating
MD
07/31FRESENIUS MEDICAL CARE AG & CO. KGAA : Release according to Article 50 of the Wp..
EQ
07/30FRESENIUS MEDICAL CARE : cuts 2020 outlook on pandemic impact
RE
07/30FRESENIUS SE : Barclays reiterates its Neutral rating
MD
07/30FRESENIUS SE : Berenberg reaffirms its Buy rating
MD
07/30FMC FRESENIUS MEDICAL CARE AG & CO K : Barclays gives a Buy rating
MD
07/30FMC FRESENIUS MEDICAL CARE AG & CO K : Goldman Sachs gives a Buy rating
MD
07/30FMC FRESENIUS MEDICAL CARE AG & CO K : Gets a Neutral rating from Bernstein
MD
More news
News in other languages on FRESENIUS MEDICAL CARE AG
11:09aFMC FRESENIUS MEDICAL CARE AG & CO K : DZ Bank toujours positif
11:09aFMC FRESENIUS MEDICAL CARE AG & CO K : Gets a Buy rating from DZ Bank
11:09aDZ Bank hebt fairen Wert für FMC auf 98,50 Euro - 'Kaufen'
07/31FRESENIUS SE : Credit Suisse toujours neutre sur le dossier
07/31FRESENIUS SE : Credit Suisse remains Neutral
More news
Analyst Recommendations on FRESENIUS MEDICAL CARE AG
More recommendations
Chart FRESENIUS MEDICAL CARE AG & CO. KGAA
Duration : Period :
Fresenius Medical Care AG & Co. KGaA Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends FRESENIUS MEDICAL CARE AG
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 22
Average target price 95,84 $
Last Close Price 87,84 $
Spread / Highest target 31,9%
Spread / Average Target 9,12%
Spread / Lowest Target -13,5%
EPS Revisions
Managers
NameTitle
Rice Powell Chairman-Management Board
Dieter Schenk Chairman-Supervisory Board
Helen Giza Chief Financial Officer
Olaf Schermeier CEO-Global Research & Development
Franklin W. Maddux Global Chief Medical Officer
Sector and Competitors